Literature DB >> 7716768

Modeling of the toxicokinetics of polychlorinated dibenzo-p-dioxins and dibenzofurans in mammalians, including humans. II. Kinetics of absorption and disposition of PCDDs/PCDFs.

G Carrier1, R C Brunet, J Brodeur.   

Abstract

In the present study, a physiologically based model which describes the absorption and disposition kinetics of PCDDs/PCDFs (globally called PCDXs) in mammalian species, including humans, is developed. The model integrates the distribution model developed in the first article of this series, which described the fractional distribution of total PCDXs between liver and adipose tissues as a function of overall body concentration (G. Carrier, R. C. Brunet, and J. Brodeur, 1995, Toxicol. Appl. Pharmacol. 131, 253-266). In particular it is shown that the liver fraction of the total body burden decreases as overall body concentration decreases. Since elimination is principally through the liver, this leads to lower global elimination rates and longer half-lives of PCDXs. Absorption and disposition kinetics of PCDXs are captured using nonlinear differential equations with anatomically and biochemically relevant input parameters which are readily available. These are solved to predict the fate of PCDXs in liver, adipose tissues, and the body as a whole, as a function of time. Model simulations are in agreement with published data on absorption and disposition kinetics of these substances in rats and in humans. The kinetic profiles are similar for rats and humans, but the varying half-lives differ considerably in both species: weeks with rats, years with humans. For a given body burden, the adipose tissue concentrations vary in an inversely proportional manner to the mass of the adipose tissues; this observation has considerable relevance for interpretation of clinical data for humans. The interest of the proposed model rests upon the fact that it is generalized and broadly applicable: it allows the study of the kinetics of PCDXs for any pattern of exposure from background to highly toxic levels, taking into account variations in time of anatomical and biochemical parameters.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7716768     DOI: 10.1006/taap.1995.1069

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  10 in total

1.  Application of pharmacokinetic modelling for 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure assessment.

Authors:  P Ruiz; L L Aylward; M Mumtaz
Journal:  SAR QSAR Environ Res       Date:  2014-11-14       Impact factor: 3.000

2.  Role of oil vehicle on hepatic cell proliferation in PCB-treated rats.

Authors:  Rodica Petruta Bunaciu; Job C Tharappel; Hans-Joachim Lehmler; Eun Y Lee; Larry W Robertson; Geza G Bruckner; Brett T Spear; Howard P Glauert
Journal:  J Environ Pathol Toxicol Oncol       Date:  2011       Impact factor: 3.567

3.  Inhalation dosimetry modeling with decamethylcyclopentasiloxane in rats and humans.

Authors:  Micaela B Reddy; Ivan D Dobrev; Debra A McNett; Joseph M Tobin; Mark J Utell; Paul E Morrow; Jeanne Y Domoradzki; Kathleen P Plotzke; Melvin E Andersen
Journal:  Toxicol Sci       Date:  2008-06-26       Impact factor: 4.849

4.  Physiologically based pharmacokinetic toolkit to evaluate environmental exposures: Applications of the dioxin model to study real life exposures.

Authors:  Claude Emond; Patricia Ruiz; Moiz Mumtaz
Journal:  Toxicol Appl Pharmacol       Date:  2016-12-10       Impact factor: 4.219

5.  Comparison of the use of a physiologically based pharmacokinetic model and a classical pharmacokinetic model for dioxin exposure assessments.

Authors:  Claude Emond; Joel E Michalek; Linda S Birnbaum; Michael J DeVito
Journal:  Environ Health Perspect       Date:  2005-12       Impact factor: 9.031

6.  Use of a physiologically based pharmacokinetic model for rats to study the influence of body fat mass and induction of CYP1A2 on the pharmacokinetics of TCDD.

Authors:  Claude Emond; Linda S Birnbaum; Michael J DeVito
Journal:  Environ Health Perspect       Date:  2006-09       Impact factor: 9.031

7.  Estimation of occupational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin using a minimal physiologic toxicokinetic model.

Authors:  K Thomaseth; A Salvan
Journal:  Environ Health Perspect       Date:  1998-04       Impact factor: 9.031

8.  Age- and concentration-dependent elimination half-life of 2,3,7,8-tetrachlorodibenzo-p-dioxin in Seveso children.

Authors:  Brent D Kerger; Hon-Wing Leung; Paul Scott; Dennis J Paustenbach; Larry L Needham; Donald G Patterson; Pier M Gerthoux; Paolo Mocarelli
Journal:  Environ Health Perspect       Date:  2006-10       Impact factor: 9.031

Review 9.  Airborne environmental injuries and human health.

Authors:  Andrea T Borchers; Christopher Chang; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2006-08       Impact factor: 8.667

10.  Infant exposure to dioxin-like compounds in breast milk.

Authors:  Matthew Lorber; Linda Phillips
Journal:  Environ Health Perspect       Date:  2002-06       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.